Market Cap 35.47M
Revenue (ttm) 16.89M
Net Income (ttm) -37.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -223.80%
Debt to Equity Ratio 0.00
Volume 83,800
Avg Vol 162,590
Day's Range N/A - N/A
Shares Out 14.66M
Stochastic %K 73%
Beta -1.01
Analysts Strong Sell
Price Target $16.33

Company Profile

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to preven...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 509 6897
Address:
2916 North Miami Avenue, Suite 1000, Miami, United States
RRDf
RRDf Dec. 5 at 1:18 AM
$VERU The current trend is showing signs of a steady rebound. The price has climbed from the 52-week low of $2.11 back to the $2.40 range, which suggests growing buying strength at the bottom. Even though the volume isn’t high, the price stability and lack of new lows are typical signs of a base forming. If the company gets any fundamental or data-driven catalyst, the stock could continue moving upward in the short term
0 · Reply
mrkymrk
mrkymrk Dec. 4 at 4:59 PM
$VERU VERU is presenting along with LLY, Regeneron and Actimed. I was unfamiliar with Actimed and after brief search it appears their approach to parenting muscle loss is to induce appetite. This would never work in comp woth GLP-1 because that the exact opposite of how the GLP work (suppresses appetite). Therefore, while Actimed might have shot in cancer patients, they will not be a player in obesity.
0 · Reply
mrkymrk
mrkymrk Dec. 4 at 2:36 PM
$VERU Mitch going to Rome for a 15 min talk. Seems appropriate for a company on their last dollar…..
0 · Reply
PlankieWalk
PlankieWalk Dec. 3 at 9:53 AM
$VERU bag holding this stuff till 2028 or more. What shitz
0 · Reply
mrkymrk
mrkymrk Nov. 30 at 2:31 PM
$VERU so they are going to waste 2 YEARS running a study with only 200 patients?!!?!? This whole team needs fucking fired. What a shitty fucking group of executives.
0 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Nov. 27 at 12:14 PM
$VERU FYI - November presentation has been posted: https://d1io3yog0oux5.cloudfront.net/_80c4d5eb0dee1f898aaff7326d5ca661/verupharma/db/2224/21095/pdf/Veru+Corporate+Presentation+-+November+2025.pdf
1 · Reply
scoobydoo16
scoobydoo16 Nov. 26 at 8:20 PM
$GUTS $VERU Tread carefully. @BioRich and @howardlindzon (CEO of Stocktwits) have special interests here, and wish to bamboozle investors into saving them from their huge losses in these 2 Gems. Just check @BioRich posts for his obsession with $ALT I have it on good authority that they work for Kerrisdale Capital, a notoriously unsuccessful firm that shorts stocks like $ALT and $CVNA, before issuing hit pieces against these companies. Pretty shady dealings here. Be careful with these Penny Stocks, and these clowns.
1 · Reply
Iightning
Iightning Nov. 26 at 6:08 AM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.43 Exit: $0.85 | Profit: 97.89% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:16 PM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.43 Exit: $0.85 | Profit: 97.89% ROI | https://1ightning.com
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Nov. 25 at 10:18 AM
How do you trade small and mid cap stocks? I buy when H% is low. Nothing else. I keep track of my results to see if my strategy worked out or not. $BBIG + $VERU will trade the same.
0 · Reply
Latest News on VERU
Veru to Present Two Abstracts at ObesityWeek 2025

Oct 31, 2025, 8:30 AM EDT - 4 weeks ago

Veru to Present Two Abstracts at ObesityWeek 2025


Veru Announces Proposed Public Offering

Oct 29, 2025, 4:01 PM EDT - 5 weeks ago

Veru Announces Proposed Public Offering


Veru Inc. (VERU) Q3 2025 Earnings Call Transcript

Aug 12, 2025, 12:57 PM EDT - 4 months ago

Veru Inc. (VERU) Q3 2025 Earnings Call Transcript


Veru Announces Reverse Stock Split

Aug 6, 2025, 8:30 AM EDT - 4 months ago

Veru Announces Reverse Stock Split


Veru to Participate in the 2025 BTIG Virtual Biotech Conference

Jul 22, 2025, 8:30 AM EDT - 4 months ago

Veru to Participate in the 2025 BTIG Virtual Biotech Conference


Veru to Participate in the Virtual BTIG Obesity Health Forum

Jun 11, 2025, 8:30 AM EDT - 6 months ago

Veru to Participate in the Virtual BTIG Obesity Health Forum


Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

May 28, 2025, 12:11 PM EDT - 6 months ago

Veru's Enobosarm Shows Muscle In Wegovy Combo Trial


Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom

May 26, 2025, 9:36 PM EDT - 6 months ago

Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom


Veru Inc. (VERU) Q2 2025 Earnings Call Transcript

May 8, 2025, 12:42 PM EDT - 7 months ago

Veru Inc. (VERU) Q2 2025 Earnings Call Transcript


Veru Participates in a Virtual Investor KOL Connect Segment

May 8, 2025, 9:25 AM EDT - 7 months ago

Veru Participates in a Virtual Investor KOL Connect Segment


Veru Inc (VERU) Q1 2025 Earnings Call Transcript

Feb 13, 2025, 2:35 PM EST - 10 months ago

Veru Inc (VERU) Q1 2025 Earnings Call Transcript


Veru Inc. (VERU) Q3 2024 Earnings Call Transcript

Aug 10, 2024, 8:39 AM EDT - 1 year ago

Veru Inc. (VERU) Q3 2024 Earnings Call Transcript


Veru to Present at the Jefferies Global Healthcare Conference

May 22, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the Jefferies Global Healthcare Conference


Veru Announces Steven B. Heymsfield M.D.

May 15, 2024, 8:30 AM EDT - 1 year ago

Veru Announces Steven B. Heymsfield M.D.


Veru to Present at the GLP-1 Based Therapeutics Summit

May 2, 2024, 8:30 AM EDT - 1 year ago

Veru to Present at the GLP-1 Based Therapeutics Summit


Veru Reschedules Annual Meeting of Shareholders

Mar 22, 2024, 4:05 PM EDT - 1 year ago

Veru Reschedules Annual Meeting of Shareholders


RRDf
RRDf Dec. 5 at 1:18 AM
$VERU The current trend is showing signs of a steady rebound. The price has climbed from the 52-week low of $2.11 back to the $2.40 range, which suggests growing buying strength at the bottom. Even though the volume isn’t high, the price stability and lack of new lows are typical signs of a base forming. If the company gets any fundamental or data-driven catalyst, the stock could continue moving upward in the short term
0 · Reply
mrkymrk
mrkymrk Dec. 4 at 4:59 PM
$VERU VERU is presenting along with LLY, Regeneron and Actimed. I was unfamiliar with Actimed and after brief search it appears their approach to parenting muscle loss is to induce appetite. This would never work in comp woth GLP-1 because that the exact opposite of how the GLP work (suppresses appetite). Therefore, while Actimed might have shot in cancer patients, they will not be a player in obesity.
0 · Reply
mrkymrk
mrkymrk Dec. 4 at 2:36 PM
$VERU Mitch going to Rome for a 15 min talk. Seems appropriate for a company on their last dollar…..
0 · Reply
PlankieWalk
PlankieWalk Dec. 3 at 9:53 AM
$VERU bag holding this stuff till 2028 or more. What shitz
0 · Reply
mrkymrk
mrkymrk Nov. 30 at 2:31 PM
$VERU so they are going to waste 2 YEARS running a study with only 200 patients?!!?!? This whole team needs fucking fired. What a shitty fucking group of executives.
0 · Reply
Woundntyouliketoknow
Woundntyouliketoknow Nov. 27 at 12:14 PM
$VERU FYI - November presentation has been posted: https://d1io3yog0oux5.cloudfront.net/_80c4d5eb0dee1f898aaff7326d5ca661/verupharma/db/2224/21095/pdf/Veru+Corporate+Presentation+-+November+2025.pdf
1 · Reply
scoobydoo16
scoobydoo16 Nov. 26 at 8:20 PM
$GUTS $VERU Tread carefully. @BioRich and @howardlindzon (CEO of Stocktwits) have special interests here, and wish to bamboozle investors into saving them from their huge losses in these 2 Gems. Just check @BioRich posts for his obsession with $ALT I have it on good authority that they work for Kerrisdale Capital, a notoriously unsuccessful firm that shorts stocks like $ALT and $CVNA, before issuing hit pieces against these companies. Pretty shady dealings here. Be careful with these Penny Stocks, and these clowns.
1 · Reply
Iightning
Iightning Nov. 26 at 6:08 AM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.43 Exit: $0.85 | Profit: 97.89% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 4:16 PM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.43 Exit: $0.85 | Profit: 97.89% ROI | https://1ightning.com
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Nov. 25 at 10:18 AM
How do you trade small and mid cap stocks? I buy when H% is low. Nothing else. I keep track of my results to see if my strategy worked out or not. $BBIG + $VERU will trade the same.
0 · Reply
Iightning
Iightning Nov. 25 at 5:10 AM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.43 Exit: $0.85 | Profit: 97.89% ROI | https://1ightning.com
0 · Reply
NolAsrtormZ
NolAsrtormZ Nov. 24 at 3:25 PM
$VERU lololololol you guys have 3 years for data and trade at the near $GRI bio share price. Why wait 3 years when data comes this week at $GRI 🤑🤑🤑🤑
1 · Reply
Iightning
Iightning Nov. 22 at 2:21 AM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.48 Exit: $0.77 | Profit: 61.28% ROI | https://1ightning.com
0 · Reply
mrkymrk
mrkymrk Nov. 21 at 1:38 PM
$VERU there has to be something about this drug that is keeping big pharma away. It can’t be the management because those assholes would all be fired day 1 of an acquisition. What is VERU not sharing with us? Otherwise it wouldn’t be a $30M market cap when others are being bought for several billion $$
2 · Reply
Ljkjr
Ljkjr Nov. 21 at 1:33 PM
$VERU It calmed my nerves to know that VERU closed on the warrants. The stock we’ll go up and down over the next year, but not to zero.
2 · Reply
Iightning
Iightning Nov. 21 at 5:43 AM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.48 Exit: $0.77 | Profit: 61.28% ROI | https://1ightning.com
0 · Reply
NolAsrtormZ
NolAsrtormZ Nov. 20 at 9:52 PM
$VERU ... has the trial started yet???? $GRI bio iPf data soon Now trades pretty close to this price. Wait 3 years for trial and data.... Or wait 1 week for Data.
0 · Reply
mrkymrk
mrkymrk Nov. 20 at 9:03 PM
$VERU these idiots don’t even proof read their own slides. They have the same slide in there twice. WTF do they do all day?
2 · Reply
BioTechChap
BioTechChap Nov. 20 at 6:57 PM
$VERU For those who are still wondering about the raise. On October 31, 2025, Veru received net proceeds from an underwritten public offering of approximately $23.4 million, after deducting the underwriting discounts and commissions and estimated costs payable by the Company, in exchange for (i) 1,400,000 shares of common stock, (ii) pre-funded warrants to purchase up to 7,000,000 shares of our common stock, (iii) accompanying Series A warrants to purchase up to 8,400,000 shares of our common stock at an exercise price of $3.00, and (iv) accompanying Series B warrants to purchase up to 8,400,000 shares of our common stock at and exercise price of $3.00
1 · Reply
Eesnimi
Eesnimi Nov. 20 at 6:31 PM
$VERU From $200 to $ 2 . This is the Veru way! Down -99% 🤣
0 · Reply
Iightning
Iightning Nov. 20 at 3:40 AM
1ightning® Options Trade Alert (Actionable) | Buy $VERU Dec 5 $5 Call | Enter: $0.48 Exit: $0.77 | Profit: 61.28% ROI | https://1ightning.com
0 · Reply
Truthseeker7856
Truthseeker7856 Nov. 19 at 11:07 PM
0 · Reply